Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy

Journal of Computer Assisted Tomography

Volumn 29, Issue 4, 2005, Pages 524-527

  Sakai, Mio ^a   Inoue, Yusuke ^b,c   Oba, Hiroshi ^d   Ishiguro, Akira ^c   Sekiguchi, Kyoko ^c   Tsukune, Yoshihiko ^c   Mitomo, Masanori ^a   Nakamura, Hironobu ^e  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c Teikyo University   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Maple syrup urine disease

Indexed keywords

BODY FLUIDS; DIAGNOSIS; DIFFUSION; MAGNETISM; NEURODEGENERATIVE DISEASES; RESONANCE;

AGE DEPENDENCE; DIFFUSION WEIGHTED IMAGES; DIFFUSION WEIGHTED IMAGING; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; MAPLE SYRUP URINE DISEASE; MYELINATION;

MAGNETIC RESONANCE IMAGING;

AGE; ARTICLE; BRAIN DISEASE; CASE REPORT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; HUMAN; MAPLE SYRUP URINE DISEASE; MYELINATION; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 23044449034     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000164667.65648.72     Document Type: Article

References (13)

1. Chung DT, Shin VE. Maple syrup urine disease (branched chain ketoaciduria) In: Scriver CR, Beaudet al, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:1971-2005.
2. Cavalleri F, Beradi A, Burlina AB, et al. Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology. 2002;44: 499-502.
3. Righini A, Ramenghi LA, Parini R, et al. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema. J Neuroimaging. 2003;13:162-165.
4. Van der Knaap MS, Valk J. Maple syrup urine disease. In: Van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin: Springer; 1995:211-215.
5. Jan W, Zimmerman RA, Wang ZJ, et al. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology. 2003;45:393-399.
6. Morton DH, Strauss KA, Robinson DL, et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002;109: 999-1008.
7. Osborn AG. Maple syrup urine disease. In: Diagnostic Imaging: Brain. Salt Lake City: Amirsys; 2004:42-45.
8. Harper PAW, Healy PJ, Dennis JA. Ultrastructural findings in maple syrup urine disease in Poll Hereford calves. Acta Neuropathol (Berl). 1986;71: 316-320.
9. Barkovich AJ. Normal development of the neonatal and infant brain, skull, and spine. In: Pediatric Neuroimaging. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:13-69.
10. Muller K, Kahn T, Wendel U. Is demyelination a feature of maple syrup urine disease? Pediatr Neurol. 1993;9:375-382.
11. Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology. 2002;222:410-418.
12. Neil J, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology. 1998; 200:57-66.
13. Morriss MC, Zimmerman RA, Bilianiuk LT, et al. Changes in brain water diffusion during childhood. Neuroradiology. 1999;41:929-934.